Search
Search Results
##search.searchResults.foundPlural##
-
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4032PDF: 1068HTML: 3607Untitled: 180Cneo. Fig.1: 117Untitled: 109Untitled: 135Untitled: 137 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2579PDF: 859HTML: 8916Efremov 1: 239Efremov 2: 205 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3380PDF: 1377HTML: 2679 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3109PDF: 888HTML: 7177Kost Fig1: 197Kost Fig 2: 189Kost Fig3: 188Kost Fig 4: 200Kost Fig5: 197Kost fig 6: 182 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3410PDF: 1501HTML: 4017 -
THE SPECTRUM OF GENETIC DEFECTS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2300PDF: 900HTML: 2008Fig 1 Rossi: 199 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1420PDF: 821HTML: 947 -
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2233PDF: 1217HTML: 3882 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2627PDF: 887HTML: 17577Fig1 Caligaris: 184Fig.2 Caliga: 229 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
2913PDF: 1250HTML: 2722Figure 1: 182 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3745PDF: 1638HTML: 83 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1681PDF: 660HTML: 2437 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2333PDF: 1345HTML: 17103Bassan Fig.1: 152Bassan Fig.2: 164Bassan Fig.4: 144Fig.3: 209 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4401PDF: 3614HTML: 226 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4207PDF: 1962HTML: 5341Table 1: 214 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2366PDF: 1015HTML: 7630Untitled: 288Fig2: 190Fig3: 181Fig4: 189 -
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3279PDF: 916HTML: 1547Fig.1 CHL-R paper: 228Fig 2 CHL-R paper: 250 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2284PDF: 1068HTML: 1990Characteristic of study group: 209 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1419HTML: 482PDF: 844 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3142PDF: 924HTML: 2075 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3804PDF: 1607HTML: 531Figures . Eliassian: 230 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3848PDF: 1694HTML: 11654Figures Haase: 214 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1409PDF: 863HTML: 143 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1587PDF: 806HTML: 222 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4449PDF: 1737HTML: 1064







